Early Tranexamic Acid and Modulating the Inflammatory Response in Sepsis
NCT04910464
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Sepsis
Interventions
DRUG:
Tranexamic acid
OTHER:
0.9% saline
Sponsor
Assiut University